Computational determination of toxicity risks associated with a selection of approved drugs having demonstrated activity against COVID-19

• Váldodahkkit: Maral Aminpour (Dahkki), Williams Ernesto Miranda Delgado (Dahkki), Soren Wacker (Dahkki), Sergey Noskov (Dahkki), Michael Houghton (Dahkki), D. Lorne J. Tyrrell (Dahkki), Jack A. Tuszynski (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: BMC, 2021-10-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Background The emergence and rapid spread of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) in thelate 2019 has caused a devastating global pandemic of the severe pneumonia-like disease coronavirus disease 2019 (COVID-19). Although vaccines have been and are being developed, t...